Aboalhasan Al-Yaqoobi, Sina Matalqah, Zainab Lafi, Anas Abed, Sara Al-Mahamid
{"title":"Dual-Loaded Curcumin-Metformin Niosomes: Physicochemical Characterization and <i>In Vitro</i> Activity in Colorectal and Pancreatic Cancer Cells.","authors":"Aboalhasan Al-Yaqoobi, Sina Matalqah, Zainab Lafi, Anas Abed, Sara Al-Mahamid","doi":"10.34172/apb.46556","DOIUrl":"10.34172/apb.46556","url":null,"abstract":"<p><strong>Purpose: </strong>Colorectal cancer and pancreatic cancer represent some of the most aggressive forms of cancer. Curcumin (CUR) and Metformin (MET) have distinct pharmacokinetic profiles. MET is water-soluble, whereas CUR is highly lipophilic. These differences in their kinetic behavior may limit their synchronized therapeutic activity when used in combination. This study aimed to develop and characterize dual-loaded curcumin-MET niosomes (NIO-CUR-MET) and evaluate their physicochemical properties, drug release behavior, and in vitro anticancer, apoptotic, and anti-inflammatory effects against HCT-116 (colorectal) and PANC-1 (pancreatic) cancer cell lines.</p><p><strong>Methods: </strong>Niosomes were prepared using the ethanol injection method and characterized using dynamic light scattering. Drug loading efficiency was determined by HPLC. Drug release was assessed over 72 hours using a dialysis method at 37°C. Anticancer activity was evaluated using the MTT assay, apoptosis via Caspase-3/7 analysis, and anti-inflammatory effects by measuring TNF-α and IL-1β levels using ELISA.</p><p><strong>Results: </strong>The particle size of 152.7±54 nm, and zeta potential of -12±1.3 mV, indicating a stable and uniform nanosystem. Encapsulation efficiencies were achieved for MET (91.5%±5%) and CUR (39.8%±7%). Release was observed ~95% for CURand ~92% for MET over 72 hours. The NIO-CUR-MET formulation significantly enhanced cytotoxicity compared to free and single-drug forms, with lower IC₅₀ values in HCT-116 (4±3.2 µM for CUR and 190±10.2 µM for MET) and PANC-1 cells IC₅₀ values (5.2±0.9 µM for CUR and 202.5±8.2 µM for MET). It also induced a 5.3-fold increase in apoptosis (<i>P</i><0.001).</p><p><strong>Conclusion: </strong>Dual-loaded niosomes improved drug delivery performance and exhibited enhanced therapeutic efficacy against target cancer cell lines.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":"16 3","pages":"537-549"},"PeriodicalIF":4.7,"publicationDate":"2026-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13745382/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Amoura M Abou-El-Naga, Aya M Abd-Elhady, Mohamed E Abdraboh, Yasmin M Tag, Maher Monir Akl
{"title":"Protodioscin Restores Ovarian Function and Suppresses p53-Bax/Bcl-2-Mediated Apoptosis in a Doxorubicin-Induced Model of Ovarian Toxicity.","authors":"Amoura M Abou-El-Naga, Aya M Abd-Elhady, Mohamed E Abdraboh, Yasmin M Tag, Maher Monir Akl","doi":"10.34172/apb.46593","DOIUrl":"10.34172/apb.46593","url":null,"abstract":"<p><strong>Purpose: </strong>This study evaluated the protective effects of protodioscin against doxorubicin (DOX)-induced ovarian injury by examining its potential to modulate hormonal alterations and apoptosis-related pathways in a rat model.</p><p><strong>Methods: </strong>Forty female Wistar rats were randomized into four groups: control, protodioscin (10 mg/kg orally for 14 days), DOX (10 mg/kg intraperitoneally on Day 7), and DOX plus protodioscin. Serum levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), anti-Müllerian hormone (AMH), and 17β-estradiol (E2) were quantified using enzyme-linked immunosorbent assay. Ovarian histopathology and immunohistochemistry were performed to evaluate tissue integrity and expression of p53, CDK4, and Survivin. Gene expression of Bax and Bcl-2 was assessed using semi-quantitative reverse transcription polymerase chain reaction (RT-PCR).</p><p><strong>Results: </strong>DOX administration significantly reduced ovarian weight by 38.5% and uterine weight by 22.6% (<i>P</i><0.01) compared with controls, accompanied by marked hormonal alterations, including increased FSH and decreased LH, AMH, and E2 levels. DOX also increased p53 and Bax expression and decreased Bcl-2 expression, resulting in an elevated Bax/Bcl-2 ratio. Co-treatment with protodioscin significantly attenuated these changes, partially restoring hormonal levels and modulating apoptosis-related markers. Protodioscin reduced p53 and Bax expression while increasing Bcl-2, CDK4, and Survivin levels, leading to a marked reduction in the Bax/Bcl-2 ratio (<i>P</i><0.05).</p><p><strong>Conclusion: </strong>Protodioscin exerts a protective effect against DOX-induced ovarian injury, likely through modulation of hormonal disturbances and apoptosis-related pathways. However, these findings should be interpreted with caution due to the absence of estrous cycle synchronization and the use of an acute DOX model.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":"16 3","pages":"647-654"},"PeriodicalIF":4.7,"publicationDate":"2026-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13745742/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Negar Namaei-Ghasemnia, Mohammad Rabiee, Fatemeh Davami, Yeganeh Talebkhan-Garoosi, Mohamad Ghorbani
{"title":"Development of a Flow Cytometric Immunoassay Using Recombinant Vascular Endothelial Growth Factor (VEGF)-Functionalized Poly(ε-Caprolactone) Microbeads for Bevacizumab Quantification.","authors":"Negar Namaei-Ghasemnia, Mohammad Rabiee, Fatemeh Davami, Yeganeh Talebkhan-Garoosi, Mohamad Ghorbani","doi":"10.34172/apb.46777","DOIUrl":"10.34172/apb.46777","url":null,"abstract":"<p><strong>Purpose: </strong>With the growing research interest in therapeutic monoclonal antibodies (mAbs) and their broad range of applications, the development of reliable analytical approaches for their quantification has become increasingly important. Since, microbead (MB)-based flow cytometric immunoassays have emerged as highly sensitive analytical methods, the aim of this study was to develop and evaluate a flow cytometry-based method using poly(ε-caprolactone) (PCL) MBs to quantify bevacizumab (BVZ) concentration.</p><p><strong>Methods: </strong>PCL MBs were synthesized through the emulsion/solvent evaporation method and modified by reaction with 1,2-ethylenediamine (EDA) to enable covalent binding of biomolecules. Based on the optimal biomolecule immobilization conditions determined using a model protein, purified recombinant vascular endothelial growth factor (VEGF) protein was immobilized on the surface of amine-functionalized MBs (A-MBs(45)) to capture BVZ, which was then detected using fluorescein isothiocyanate (FITC)-conjugated anti-human IgG antibody in flow cytometry.</p><p><strong>Results: </strong>The synthesized PCL MBs, with an average diameter of 6.62±0.17 µm, were within the suitable particle size range for immunoassay applications. The optimal aminolysis time was found to be 45 min at 37 °C, and the maximum protein coupling was achieved 5 h post-incubation at pH 8.0. The developed MB-based flow cytometric immunoassay demonstrated the potential to quantify BVZ with a limit of detection (LOD) and limit of quantification (LOQ) of about 6.71 and 22.73 ng mL-1, respectively.</p><p><strong>Conclusion: </strong>Considering the ease of fabrication and functionalization of PCL MBs under the obtained optimal conditions, along with their capability for analyte detection, these cost-effective analytical platforms may serve as promising candidates for BVZ quantification.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":"16 3","pages":"676-689"},"PeriodicalIF":4.7,"publicationDate":"2026-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13745744/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Soheil Abbaspour-Ravasjani, Rahim Shahvalizadeh, Malahat Safavi, Mina Afrashteh Nour, Mahdi Talebi, Maryam Mohammadi, Hamed Hamishehkar
{"title":"pH-Sensitive Folate-Targeted Liposomal Vitamin D Reprograms EZH2/STAT3 Axis and Induces Apoptosis, ROS, and Autophagy in MCF-7 Breast Cancer Cells.","authors":"Soheil Abbaspour-Ravasjani, Rahim Shahvalizadeh, Malahat Safavi, Mina Afrashteh Nour, Mahdi Talebi, Maryam Mohammadi, Hamed Hamishehkar","doi":"10.34172/apb.46791","DOIUrl":"10.34172/apb.46791","url":null,"abstract":"<p><strong>Purpose: </strong>Vitamin D3 (Vit D3) possesses pleiotropic anticancer activity; however, its clinical application is limited by poor bioavailability and nonselective cellular uptake. This study aimed to develop folate (FA)-targeted, pH-sensitive liposomes for enhanced delivery of Vit D3 to breast cancer cells and to evaluate their effects on the VDR/EZH2/STAT3 signaling axis.</p><p><strong>Methods: </strong>Vit D3-loaded pH-sensitive liposomes were formulated and characterized for particle size, zeta potential, encapsulation efficiency, stability, and pH-responsive release. Cellular uptake, cytotoxicity, clonogenicity, apoptosis, reactive oxygen species (ROS) generation, autophagy, cell-cycle distribution, RT-qPCR, and Western blotting were evaluated in MCF-7 cells.</p><p><strong>Results: </strong>The optimized formulations exhibited nanoscale particle size, high encapsulation efficiency, physicochemical stability, and enhanced acidic pH-triggered release. FA-targeted liposomes significantly increased cellular uptake and cytotoxicity compared with free Vit D3 and non-targeted liposomes, with IC<sub>50</sub> values of 15, 11, and 7.2 IU·mL<sup>-1</sup>, respectively. Vit D3-PEG/lipo-FA induced a 3.2-fold upregulation of VDR expression while suppressing EZH2 and STAT3 expression by 60% and 50%, respectively. In addition, treatment increased Caspase-3, LC3B, and NOX4 expression, promoted apoptosis and ROS generation, altered cell-cycle progression, and markedly reduced clonogenic survival. Western blot analysis confirmed these molecular alterations at the protein level.</p><p><strong>Conclusion: </strong>FA-targeted pH-sensitive liposomal delivery significantly enhances the anticancer efficacy of Vit D3 in MCF-7 cells by modulating the VDR/EZH2/STAT3 axis and activating apoptosis-, autophagy-, and ROS-associated pathways, highlighting its potential as a targeted nanotherapeutic strategy for breast cancer treatment.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":"16 3","pages":"550-561"},"PeriodicalIF":4.7,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13745439/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Autophagy Modulation Influenced the Spermatogenesis in Rodent Testicular Organoids and Diabetic Condition.","authors":"Shadi Atazadeh, Maryam Hasan Sadeh, Farah Farokhi, Shahin Ahmadian, Sepideh Saghati, Fereshteh Valipour, Amir Fattahi, Amin Tamadon, Reza Rahbarghazi, Mahdi Mahdipour","doi":"10.34172/apb.46240","DOIUrl":"10.34172/apb.46240","url":null,"abstract":"<p><strong>Purpose: </strong>Here, the effect of autophagy activity was investigated in rat testicular organoids embedded in alginate/gelatin (Alg/Gel) hydrogel. Additionally, we monitored the spermatogenesis potential in diabetic mice following the administration of metformin (Met) and/or hydroxychloroquine (HCQ).</p><p><strong>Methods: </strong>Alg/Gel hydrogel was fabricated, and its physicochemical properties were studied. The survival rate of freshly isolated rat whole testicular tissue cells being plated on the Alg/Gel hydrogel surface was monitored after 7 days. Rat testicular organoids were embedded in Alg/Gel hydrogel and exposed to 15 µM HCQ and/or 5 µM Met for 7 days. Histological examination was conducted to assess OCT3/4+ progenitors and maturing sperm cells. Using western blotting, the levels of autophagic markers Beclin-1, LC3, and P62 were evaluated. Diabetic mice received 120 mg/kg body weight Met and/or 70 mg/kg bodyweight HCQ for 4 weeks, followed by histological examinations and sperm analysis.</p><p><strong>Results: </strong>The fabricated Alg/Gel hydrogel demonstrated suitable physicochemical properties, which correlated with an increased survival rate of whole testicular tissue cells compared to the control group (<i>P</i><0.05). Data indicated a promotion of autophagy (Beclin-1↑, LC3-II/-I ratio↑, P62↓) and an inhibition of autophagy (LC3↓) in testicular organoids after treatment with Met and HCQ, respectively, compared to the control group (<i>P</i><0.05). These changes were accompanied by an induction of SOD activity in Met-treated testicular organoids (<i>P</i><0.05). In the presence of Met and HCQ, OCT3/4+ progenitors were reduced in rat organoids compared to non-treated control organoids (<i>P</i><0.05). Administration of Met, but not HCQ, in diabetic mice was able to restore some sperm parameters, such as motility, and reduce abnormal morphologies compared to the matched diabetic mice (<i>P</i><0.05).</p><p><strong>Conclusion: </strong>Regulation of autophagy can influence spermatogenesis capacity, affecting seminiferous tubule progenitors, maturation, and sperm parameters. In studies of rat testicular organoids and diabetic mice, these findings suggest that the autophagy response is a promising signaling pathway target in subfertile or infertile males.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":"16 3","pages":"593-605"},"PeriodicalIF":4.7,"publicationDate":"2026-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13745753/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Leila Hosseini, Seyed Mehdi Vatandoust, Narmin Farazi, Amir Pasokh, Saeed Sadigh-Eteghad, Mohammad Farzipour, Fereshteh Farajdokht, Alireza Mohajjel Nayebi, Ali Hassanzadeh, Javad Mahmoudi
{"title":"Sericin Improves Cognitive Outcomes in a Mouse Model of Cerebral Ischemia: The Role of Blood-Brain Barrier Disruption and Edema.","authors":"Leila Hosseini, Seyed Mehdi Vatandoust, Narmin Farazi, Amir Pasokh, Saeed Sadigh-Eteghad, Mohammad Farzipour, Fereshteh Farajdokht, Alireza Mohajjel Nayebi, Ali Hassanzadeh, Javad Mahmoudi","doi":"10.34172/apb.46668","DOIUrl":"10.34172/apb.46668","url":null,"abstract":"<p><strong>Purpose: </strong>Oxidative stress, edema, and blood-brain barrier (BBB) dysfunction are involved in the pathophysiology of stroke and may offer opportunities for managing its related insults. Sericin (Ser) has neuroprotective and pro-cognitive effects. This study aimed to determine whether Ser could reduce cerebral edema and its associated molecular and cognitive abnormalities in a mouse model of cortical ischemia.</p><p><strong>Methods: </strong>The mice were allocated into five cohorts: Sham, normal saline (NS), Ser200, Ser300, and Ser400. Each group received its treatment for 14 days before being subjected to cerebral ischemia or a sham surgery procedure. Spatial memory was assessed using the Lashley III maze. Brain edema, BBB permeability, malondialdehyde (MDA) level, and changes in anti-oxidant markers (total antioxidant capacity (TAC), as well as superoxide dismutase (SOD) and glutathione peroxidase (GPx) activities) were evaluated in the brain samples. Additionally, the expression of BBB structural integrity proteins, including occludin and zonula occludens-1 (ZO-1), and matrix metalloproteinase-9 (MMP-9), were analyzed.</p><p><strong>Results: </strong>Ser300 and Ser400 improved spatial memory (at least <i>P</i><0.05). Also, Ser400 reduced brain water content (<i>P</i><0.05), Ser300 and 400 decreased BBB leakage (at least <i>P</i><0.05), and normalized anti-oxidant markers (at least <i>P</i><0.05). As well, Ser400 diminished MDA content (<i>P</i><0.05). All doses decreased MMP-9 levels (at least <i>P</i><0.01). Ser400 upregulated the expression of occludin (<i>P</i><0.01), and Ser300 and 400 increased ZO-1 proteins (at least <i>P</i><0.05).</p><p><strong>Conclusion: </strong>Ser improved cognitive dysfunction associated with BBB damage and edema induced by cerebral ischemia in a mouse model.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":"16 3","pages":"655-664"},"PeriodicalIF":4.7,"publicationDate":"2026-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13745743/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sushrut Joshi, Chitrali Talele, Gunosindhu Chakraborthy, Manisha Lalan, Sachin Mali
{"title":"Development of Cloned B Cell Populations as Immunotherapeutic Agents Against MYC Carcinogenic Proteins.","authors":"Sushrut Joshi, Chitrali Talele, Gunosindhu Chakraborthy, Manisha Lalan, Sachin Mali","doi":"10.34172/apb.46527","DOIUrl":"10.34172/apb.46527","url":null,"abstract":"<p><p>The MYC proto-oncogene is one of the most extensively dysregulated transcription factors in cancer, governing cell cycle progression, metabolic adaptation, and immune evasion. Despite its central role in tumor biology, MYC has been considered an undruggable target due to its nuclear localization, lack of enzymatic activity, and involvement in transcriptional regulation. The emergence of B-cell based immunotherapies has reshaped the understanding of tumor immunology, revealing that B cells exert both effector and regulatory roles in tumor microenvironment. The intersection between MYC biology and B-cell function is relevant, as MYC is indispensable for B-cell maturation and is frequently dysregulated in B-cell-derived malignancies such as Burkitt lymphoma and diffuse large B-cell lymphoma. We focus specifically on the intersection between MYC-driven oncogenic signaling and emerging B-cell-based immunotherapeutic platforms. This review proposes a conceptual reference framework in which MYC is considered not only as a proliferative driver but also as an immune-modulating oncogene that can aid in the design of humoral therapeutic strategies. Therapeutic strategies to inhibit MYC are systematically discussed, including BET and CDK inhibitors, disruption of MYC-MAX dimerization, RNA-based technologies, synthetic lethality approaches, and emerging PROTACs. Cloned B-cell populations, effector B-cells secreting intrabodies, CAR-B platforms, and antibody-based intracellular targeting are areas of focus. An overview is presented of preclinical and clinical advances made thus far, as well as challenges to the successful translation of these therapies for use in patients including tumor heterogeneity, limitations associated with delivery of agents, and risk of inducing autoimmunity. Forecasting the future provides rationale for combining MYC-targeting agents with immunotherapies and using personalized neoantigen-driven B-cell immunotherapies to treat patients with cancer. Overall, these findings support the concept that MYC B-cell-directed strategies will represent a novel means of treating patients with cancer through their development into new classes of therapeutics.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":"16 3","pages":"495-506"},"PeriodicalIF":4.7,"publicationDate":"2026-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13745433/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comparative Analysis of MAR and Terminator Elements in Controlling Stable EPO Expression in CHO-K1 Cells.","authors":"Fatemeh Jalali, Shahriyar Abdoli, Fatemeh Shamsabadi, Ahad Yamchi, Anvarsadat Kianmehr, Majid Shahbazi","doi":"10.34172/apb.45955","DOIUrl":"10.34172/apb.45955","url":null,"abstract":"<p><strong>Purpose: </strong>Chromosome remodeling, mRNA 3' end extension diversity, mRNA maturation, and the utilization of upstream and downstream DNA elements have been shown to significantly impact the production of recombinant proteins. In this study, we employed the human beta-globin Matrix Attachment Region (β-MAR) as an upstream element and the human beta-globin terminator (β-TERM) as a downstream section to augment erythropoietin (EPO) production.</p><p><strong>Methods: </strong>Four plasmids expressing the EPO transgene, after optimization for codon bias and secondary structure of the EPO mRNA, were transfected into CHO-K1 cells. Two weeks after antibiotic selection, pooled stable clones were evaluated for gene copy number (GCN), mRNA quantification, and EPO expression level.</p><p><strong>Results: </strong>Our results revealed a significant increase in the amount of EPO secreted by stable CHO cells in the presence of β-MAR. At the same time, β-TERM had no noticeable impact on EPO production. As expected, the presence of the β-MAR sequence resulted in a higher gene copy number with 15 gene copy per cell (GCN/cell) and mRNA quantity with 5.3 fold change, leading to a much greater secretion of EPO with 28.3 mIU/ml compared to the β-TERM sequence with 3 GCN/cell, 2.8 mRNA fold change and 8.2 mIU/ml of EPO quantity. In the other construct incorporating both β-MAR and β-TERM elements, a gene copy number (GCN) of 7.0 per cell was detected, accompanied by a 4.58-fold elevation in mRNA expression and a secreted erythropoietin (EPO) concentration of 22.45 mIU/ml. In contrast, the construct devoid of both β-MAR and β-TERM (used as the calibrator) elements demonstrated a GCN of 1.0 per cell, an mRNA expression fold change of 1.0, and an EPO concentration of 8.35 mIU/ml.</p><p><strong>Conclusion: </strong>This experiment further supports previous studies, demonstrating the significant impact of the β-MAR element on recombinant protein production in stable CHO-K1 cells.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":"16 3","pages":"562-572"},"PeriodicalIF":4.7,"publicationDate":"2026-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13745386/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Fardin Khajepour, Mehdi Ranjbar, Merat Mahmoodi, Nasrin Bazargan, Fatemeh Mohammadi Henjeroei, Muhammad Hossein Ashoub, Reza Nosratabadi
{"title":"Royal Jelly-Loaded LDH Nanostructures: A Novel Topical Therapy for Atopic Dermatitis via Inflammasome Suppression in Mice.","authors":"Fardin Khajepour, Mehdi Ranjbar, Merat Mahmoodi, Nasrin Bazargan, Fatemeh Mohammadi Henjeroei, Muhammad Hossein Ashoub, Reza Nosratabadi","doi":"10.34172/apb.46710","DOIUrl":"10.34172/apb.46710","url":null,"abstract":"<p><strong>Purpose: </strong>Atopic dermatitis (AD) is a chronic autoimmune disease of the skin, resulting from immune dysregulation and inflammasome activation. This study aimed to develop and evaluate a topical formulation of layered double hydroxide (LDH) nanostructures loaded with royal jelly (RJ) for its therapeutic effects on AD in a mouse model.</p><p><strong>Methods: </strong>LDH nanostructures were synthesized, and characterized by nanoparticle specific tests. The RJ-loaded nanostructures were incorporated into a carbomer-based gel, and sustained release of RJ was measured using a Franz diffusion cell. AD was induced in female BALB/c mice using 2, 4-dinitrochlorobenzene (DNCB)-induced AD. The mice were then divided into six groups: control, Free-RJ (100 mg/kg), Free-LDH, and RJ-loaded LDH at different doses (50, 100, and 200 mg/kg).</p><p><strong>Results: </strong>Treatment with RJ-loaded LDH nanostructures significantly diminished the expression of inflammasome-related genes (NLRP3, Caspase-1, IL-1β, and IL-18) in spleen cells in a dose-dependent manner. Serum levels of IL-1β, IL-18, and IgE were also significantly decreased, and histopathological analysis revealed reduced epidermal thickening and inflammation in the treated groups.</p><p><strong>Conclusion: </strong>These findings suggest that RJ-loaded LDH nanostructures enhance RJ's anti-inflammatory and immunomodulatory effects, offering a promising topical therapeutic strategy for AD management.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":"16 3","pages":"665-675"},"PeriodicalIF":4.7,"publicationDate":"2026-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13745750/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nur Aqilah Nadhirah Affendie, Nurul Syahmin Ab Aziz, Siti Yusrina Nadihah Jamaludin, Normala Abd Latip, Aisyah Hasyila Jahidin
{"title":"Interplay Between Endolysosomal Calcium Signalling, EMT, and Autophagy in Colorectal Cancer (CRC): Implications for Metastasis and Therapeutic Strategies.","authors":"Nur Aqilah Nadhirah Affendie, Nurul Syahmin Ab Aziz, Siti Yusrina Nadihah Jamaludin, Normala Abd Latip, Aisyah Hasyila Jahidin","doi":"10.34172/apb.45688","DOIUrl":"10.34172/apb.45688","url":null,"abstract":"<p><p>Colorectal cancer (CRC) is a form of cancer that, while initially slow to develop, becomes aggressive and poses significant treatment challenges in its later stages, often resulting in a low survival rate. This progression is evident, with patients having an approximate 90% five-year survival rate at the localised stage CRC, which drops dramatically to 12.5% for those with distant metastases. Epithelial-to-mesenchymal transition (EMT) plays a pivotal role in metastases, as it facilitates the spread of cancer cells to migrate from the primary site to secondary locations. Autophagy further supports this process by enhancing cell survival under stress. Both EMT and autophagy are tightly regulated by calcium signalling, which is essential for cancer cell migration, invasion, and survival under unfavourable conditions. Targeting specific calcium channels and signalling pathways can inhibit EMT and regulate autophagy, thereby reducing cancer metastasis. This review explores the intricate relationship between endolysosomal (EL) calcium signalling, EMT, and autophagy in CRC, highlighting potential therapeutic strategies and the significance of these findings for improving treatment outcomes.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":"16 3","pages":"482-494"},"PeriodicalIF":4.7,"publicationDate":"2026-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13745432/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149376807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}